%0 Journal Article %A Anubhuti Mishra %A Staci Sutermaster %A Peter Smittenaar %A Nicholas Stewart %A Sema K. Sgaier %T COVID-19 Vaccine Coverage Index: Identifying barriers to COVID-19 vaccine uptake across U.S. counties %D 2021 %R 10.1101/2021.06.17.21259116 %J medRxiv %P 2021.06.17.21259116 %X Importance The United States is in a race against time to vaccinate its population to contain the COVID-19 pandemic. With limited resources, a proactive, targeted effort is needed to reach widespread community immunity.Objective Identify county-level barriers to achieving rapid COVID-19 vaccine coverage and validate the index against vaccine rollout data.Design Ecological studySetting Population-basedParticipants Longitudinal COVID-19 vaccination coverage data for 50 states and the District of Columbia and 3118 counties from January 12 through May 25, 2021.Exposure(s) The COVID-19 Vaccine Coverage index (CVAC) ranks states and counties on barriers to coverage through 28 indicators across 5 themes: historic undervaccination, sociodemographic barriers, resource-constrained health system, healthcare accessibility barriers, and irregular care-seeking behaviors. A score of 0 indicates the lowest level of concern, whereas a score of 1 indicates the highest level of concern.Main Outcome(s) and Measure(s) State-level vaccine administrations from January 12 through May 25, 2021, provided by the Centers for Disease Control and Prevention (CDC) and Our World In Data. County-level vaccine coverage as of May 25, 2021, provided by the CDC.Results As of May 25, 2021, the CVAC strongly correlated with the percentage of population fully vaccinated against COVID-19 by county (r = -0.39, p=2.2×10−16) and state (r=-0.77, p=4.9×10−11). Low-concern states and counties have fully vaccinated 26.5% [t=6.8, p=1.7×10−7] and 26% (t=22.0, p=2.2×10−16) more people, respectively, compared to their high-concern counterparts. This vaccination gap is at its highest point since the start of vaccination and continues to grow. Higher concern on each of the five themes predicts a lower rate of vaccination at the county level (all p<.001). We identify five types of counties with distinct barrier profiles.Conclusions and Relevance The CVAC measures underlying barriers to vaccination and is strongly associated with the speed of rollout. As the coverage gap between high- and low-concern regions continues to grow, the CVAC can inform a precision public health response targeted to underlying barriers.Question Which U.S. counties face barriers to COVID-19 vaccine rollout, and are these communities vaccinating fewer individuals?Findings The COVID-19 Vaccine Coverage Index (CVAC) comprises five themes reflecting county-level concern for low coverage. We report rural, regional, and racial divides in exposure to these vaccination barriers. The top third of states and counties of highest concern have vaccinated 19% and 20% fewer people, respectively, compared to regions of least concern.Meaning The CVAC can help contextualize progress to widespread COVID-19 vaccine coverage, identifying underlying community-level factors that could be driving suboptimal rollout to inform precision solutions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No research was conducted on human subjectsAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe COVID-19 Vaccine Coverage Index and an interactive data explorer are available at the Surgo Venture website. COVID-19 vaccine data is available from the CDC vaccine dashboard and Texas' COVID-19 vaccination dashboard https://vaccine.precisionforcovid.org/ https://covid.cdc.gov/covid-data-tracker/#vaccinations-county-view https://tabexternal.dshs.texas.gov/t/THD/views/COVID-19VaccineinTexasDashboard/Summary?:origin=card_share_link&:embed=y&:isGuestRedirectFromVizportal=y %U https://www.medrxiv.org/content/medrxiv/early/2021/06/22/2021.06.17.21259116.full.pdf